Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Lecco
Clinical trial register · Italy

Clinical Trials in Lecco, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Italy and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 6791 matching records held by the registry are in this view. Synced 11 Oct 2026, 03:19 UTC
6791
Studies in scope
all four open statuses
4079
Recruiting now
open to new participants
1019
Lead sponsors
across recruiting studies
Top sites
Milan 2846 Bologna 1303 Roma 1272 Naples 983 Rome 968
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AstraZeneca7 Gilead Sciences3 IRCCS San Raffaele2 Janssen Research & Development, LLC2 UNICANCER1
Site location
Milan2846 Bologna1303 Roma1272 Naples983 Rome968
All 489 locations
Target enrolment
to

Trials with a site in Lecco

44 of 6791 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Italy
Start
Not yet open
IRCCS San Raffaele
Observational
50,000
Lecco, Milan, Novara, Varese
2026-07
Recruiting
Optimising Adjuvant Chemotherapy Prescription in Young Patients With Hormone-dependent Breast Cancer Using Genomic Tests
NCT07106632Early Breast Cancer, Premenopausal Breast Cancer, HR+/HER2- Breast Cancer
UNICANCER
Phase 3
3,380
Aviano, Bergamo, Carpi, Crema, Florence, Genova, Lecco, Meldola
2026-06-26
Recruiting
Merck Sharp & Dohme LLC
Phase 3
900
Brescia, Lecco, Milan, Padova, Roma, Torino
2026-02-16
Recruiting
Tolerability of Remimazolam Versus Midazolam in EUS
NCT07600073Sedation During GI Endoscopy
Azienda Socio Sanitaria Territoriale di Lecco
Observational
126
Lecco
2026-02-01
Recruiting
AstraZeneca
Phase 3
1,100
Brescia, Catania, Florence, Lecco, Milan, Naples, Parma, Pisa
2025-12-29
Recruiting
Incyte Corporation
Phase 3
466
Alba, Alessandria, Aviano, Bologna, Florence, Lecco, Milan, Mirano
2025-12-09
Recruiting
Novo Nordisk A/S
Phase 3
1,280
Ancona - Torrette, Bologna, Bolzano, Brescia, Cona, Florence, Ivrea, Lecco
2025-10-02
Recruiting
Daiichi Sankyo
Phase 3
710
Bari, Bologna, Florence, Lecco, Milan, Torino
2025-09-30
Recruiting
European Institute of Oncology
Observational
750
Bergamo, Brescia, Brindisi, Crema, Lecco, Legnano, Milan, Modena
2025-09-29
Recruiting
Alnylam Pharmaceuticals
Phase 3
11,000
Ancona, Cittadella, Lecco, L’Aquila, Messina, Milan, Naples, Novara
2025-09-22
Recruiting
Early Ravulizumab Treatment Of Anti- AChR Antibody-Positive Generalized Myasthenia Gravis
NCT06967480Generalized Myasthenia Gravis, Anti-AChR Antibody Positive
DrugRavulizumab
Alexion Pharmaceuticals, Inc.
Observational
40
Bergamo, Bologna, Brescia, Florence, Imperia, Lecco, Messina, Milan
2025-07-31
Recruiting
AstraZeneca
Phase 3
830
Candiolo, Lecco, Lucca, Meldola, Milan, Naples, Peschiera del Garda, Pisa
2025-04-10
Recruiting
Speech Therapy and Parenting for Early Socio-communicAtive sKills
NCT06666777Neurological Impairments, Genetic Syndrome, Neurodevelopmental Disability, Developmental Delays
IRCCS Eugenio Medea
Not applicable
60
Como, Ponte Lambro, Bosisio Parini, Lecco, Sesto San Giovanni, Carate Brianza, Cislago, Vedano Olona
2025-03-19
Recruiting
TeleNEURO-Rehabilitation Systems for Neurodegenerative Conditions: the FIT4TeleNEURO Pragmatic Trial
NCT06685744Parkinson Disease, Multiple Sclerosis, Neurologic Diseases, General
Fondazione Don Carlo Gnocchi ETS
Not applicable
300
Bari, Genova, Lecco, Milan, Modena, Pavia
2024-10-23
Recruiting
North Eastern German Society of Gynaecological Oncology
Phase 2
640
Bologna, Brescia, Lecco, Milan, Monserrato, Padova, Pisa, Reggio Emilia
2024-10-11
Recruiting
Diagnosis and Treatment of Late Neurological Ischemic Deficit in Patients Suffering From Subarachnoid Hemorrhage.
NCT06804421Aneurysmal Subarachnoid Haemorrhage, Delayed Ischemic Neurological Deficit
Fondazione IRCCS San Gerardo dei Tintori
Observational
1,400
Bergamo, Bologna, Brescia, San Fermo della Battaglia, Cremona, Florence, Genova, Lecco
2024-09-28
Active, closed
Gilead Sciences
Phase 3
640
Aviano, Florence, Lecco, Meldola, Milan, Padova, Pisa, Roma
2024-08-28
Recruiting
ARCAGY/ GINECO GROUP
Phase 3
250
Alessandria, Bologna, Florence, Lecco, Milan, Venice
2024-07-30
Recruiting
University Hospital, Antwerp
Phase 3
174
Milan, Arezzo, Bergamo, Brescia, Florence, Lecco, Pavia, Pisa
2024-05-24
Recruiting
VE303 for Prevention of Recurrent Clostridioides Difficile Infection
NCT06237452Clostridium Difficile, Clostridium Difficile Infections, Clostridium Difficile Infection Recurrence, Clostridioides Difficile Infection
Vedanta Biosciences, Inc.
Phase 3
852
Alessandria, Lecco, Milan, Monza, Naples, Pavia, Modena, Roma
2024-05-20
Recruiting
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Phase 4
84
Brescia, Lecco, Padova, Aviano, Torino, Milan
2024-02-26
Recruiting
Italfarmaco
Phase 3
138
Lecco, Milan, Padova, Roma
2024-02-19
Recruiting
Elacestrant for Treating ER+/HER2- Breast Cancer Patients With ctDNA Relapse (TREAT ctDNA)
NCT05512364ER-positive Breast Cancer, HER2-negative Breast Cancer, Stage IIB Breast Cancer, Stage III Breast Cancer
DrugsElacestrant·Tamoxifen·Exemestane·Anastrozole
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3
220
Aviano, Bergamo, Cattolica, Florence, Genova, Guastalla, Lecco, Legnano
2023-12-15
Active, closed
Ipsen
Observational
1,057
Foggia, Lecco, Milan, Novara, Salerno, Verona
2023-11-01
Recruiting
DESTINY Breast Respond HER2-(Ultra)Low Europe
NCT05945732Unresectable Breast Cancer, Metastatic Breast Cancer, HER2-low Expressing Breast Cancer, HER2-(Ultra)Low Expressing Breast Cancer
DrugTrastuzumab deruxtecan
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company
Observational
2,295
Alessandria, Chieti, Città di Castello, Empoli, Lecce, Lecco, Legnago, Legnano
2023-10-24
Recruiting
AstraZeneca
Phase 3
800
Bari, Bologna, Catania, Florence, Lecco, Milan, Monza, Naples
2023-09-22
Active, closed
Mario Negri Institute for Pharmacological Research
Phase 4
190
San Fermo della Battaglia, Brescia, Florence, Lecco, Lucca, Milan, Padova, Parma
2023-09-15
Recruiting
Kartos Therapeutics, Inc.
Phase 2/3
268
Catania, Forlì, Genoa, Lecco, Lucca, Milan, Parma, Piacenza
2023-07-17
Active, closed
Janssen Research & Development, LLC
Phase 3
12,523
Brescia, Cremona, Foligno, Genova, Gubbio, Lecce, Lecco, L’Aquila
2023-02-15
Recruiting
GBG Forschungs GmbH
Phase 2
170
Alessandria, Ancona, Carpi, Lecco, Legnago, Milan, Pavia, Udine
2023-01-02
Active, closed
AstraZeneca
Phase 3
1,350
Florence, Lecco, Messina, Naples, Orbassano, Padova, Parma, Peschiera del Garda
2022-12-29
Recruiting
Canadian Cancer Trials Group
Phase 2
393
Florence, Brescia, Lecco, Milan, Rome
2022-12-19
Active, closed
Gilead Sciences
Phase 3
443
Bari, Bologna, Brescia, Genova GE, Lecco, Lucca, Milan, Monza
2022-07-25
Active, closed
Gilead Sciences
Phase 3
623
Bari, Bologna, Brescia, Genova GE, Lecco, Lucca, Milan, Monza
2022-07-20
Active, closed
AstraZeneca
Phase 3
185
Ancona, Bologna, Brescia, Candiolo, Catania, Lecce, Lecco, Milan
2020-08-04
Recruiting
Use of Fosfomycin in the Treatment of Bacterial Infections
NCT06814899Analyze the Medical Records of Patients Admitted At ASST Lecco from 01/04/2020 to 31/12/2023 Treated with Fosfomycin IV
DrugFosfomycin
Azienda Ospedaliera di Lecco
Observational
300
Lecco
2020-04-01
Active, closed
Fondazione Ricerca Traslazionale
Phase 2
206
Ponderano, Lecco, Catania, Grosseto, Province of Macerata, Monza, Modena, Piacenza
2020-03-02
Not yet open
Hepatocarcinoma Recurrence on the Liver Study - Part2
NCT04053231Liver Cancer, Surgery, Recurrence Tumor, Cirrhosis
University of Milano Bicocca
Observational
3,000
Bari, Bologna, Bolzano, Brescia, Forlì, Lecco, Mantua, Milan
2019-09
Active, closed
AstraZeneca
Phase 3
1,407
Brescia, Lecce, Lecco, Milan, Mirano, Naples, Reggio Calabria, Reggio Emilia
2019-01-04
Active, closed
Travere Therapeutics, Inc.
Phase 3
406
Ranica, Milan, Bari, Catania, Catanzaro, Lecco, Modena, Pavia
2018-12-11
Active, closed
IRCCS San Raffaele
Observational
200
Lecco, Milan, Modena, Roma, Florence, Sassari, Verona
2018-10-30
Active, closed
Janssen Research & Development, LLC
Phase 1/2
125
Bergamo, Candiolo, Carpi, Catania, Ferrara, Lecco, Livorno, Milan
2018-04-05
Active, closed
AstraZeneca
Phase 2
273
Ancona, Bologna, Brescia, Cona, Genova, Lecco, Meldola, Messina
2018-03-07
Active, closed
Breast Cancer Trials, Australia and New Zealand
Not applicable
1,167
Lecco, Milan
2017-08-21
Rows per page Showing 1–44 of 44
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Italian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 11 October 2026. https://priyalifescience.com/clinical-trials-italy/city/lecco

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Italy and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 6,791 studies in total at the last sync on 11 Oct 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 44 of those studies with a site in Lecco.

How many clinical trials are recruiting in Lecco?

27 of the 44 studies on this page are recruiting new participants as of the 11 Oct 2026, 03:19 UTC sync. A further 2 have not yet opened recruitment, 15 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Lecco), 44 studies
PhaseStudiesRecruitingShare
Phase 3221450%
Observational10622.7%
Phase 25311.4%
Not applicable326.8%
Phase 4214.5%
Phase 1/2102.3%
Phase 2/3112.3%

Most active sponsors

Lead sponsors with the most studies (Lecco)
Lead sponsorStudiesRecruiting
AstraZeneca73
Gilead Sciences30
IRCCS San Raffaele20
Janssen Research & Development, LLC20
Alexion Pharmaceuticals, Inc.11
Alnylam Pharmaceuticals11
ARCAGY/ GINECO GROUP11
Azienda Ospedaliera di Lecco11
Azienda Socio Sanitaria Territoriale di Lecco11
Breast Cancer Trials, Australia and New Zealand10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.